Transformingcare.
PHYSICIANS
SPONSORS
PATIENTS
Let’s work together.
We’re taking on NASH with strong research partnerships and innovative approaches that leverage a proven platform. You can be part of it.
Featured news
ObjectiveGI Partnering with ARcare to Provide Advanced Diagnostics and Cutting-Edge Treatment Options for Patients
The clinically integrated research platform will provide thousands of patients with chronic digestive health conditions in the ARcare network access to advanced care options. NASHVILLE, TN, September 1, 2020 – ObjectiveGI, the integrated research and technology services platform company, announced today it has partnered with ARcare, a federally qualified health care system in Arkansas, Kentucky and Mississippi, to bring advanced diagnostics ...
International NASH Day – Bringing the disease into focus
Today, June 12, marks the third annual International NASH Day. The NASH Education Program started this campaign in 2018 to raise awareness and urgency around nonalcoholic fatty liver disease (NAFLD) and its more advanced form, nonalcoholic steatohepatitis (NASH). The Global Liver Institute continues to spearhead a consortium of patient advocacy organizations, as well as medical and professional groups, to shine ...
Our gut microbes influence our reactions to medications, new research shows.
A number of studies have found that certain strains of bacteria within a patient’s microbiome can impact their body’s response to medication – in both positive and negative ways. Read more to learn about these discoveries.
Evidence in favor of blood testing shows new technology surpassing anticipated milestones.
Despite past fraudulent claims about this technology from Theranos – the now-infamous and defunct healthcare company – blood testing capabilities are fast outpacing previous predictions in the medical field. Take a look at this FierceBiotech article to learn more.